Kofi Kouame1, Aniekan Imo Peter1, Edidiong Nnamso Akang2,1, Misturah Adana1, Roshila Moodley3, Edwin Coleridge Naidu1, Onyemaechi Okpara Azu4,1. 1. Discipline of Clinical Anatomy, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal , Durban , South Africa. 2. Department of Anatomy, College of Medicine, University of Lagos , Lagos , Nigeria. 3. School of Chemistry and Physics, University of KwaZulu-Natal , Westville Campus, Durban , South Africa. 4. Department of Anatomy, School of Medicine, University of Namibia , Windhoek , Namibia.
Abstract
This study investigated the toxic effects of silver on the kidneys and livers of Sprague-Dawley rats after administering multiple doses of silver nanoparticles synthesized using extracts of Cinnamomum cassia (CcAgNPs). Twenty-four Sprague-Dawley rats (250 ± 20 g) were randomly assigned to four groups (A-D) of six animals per group and treated for 8 weeks. Group A was administered 200 mg/kg of Cinnamon Cassia extract (Cc), group B 5 mg/kg of CcAgNPs, group C 10 mg/kg of CcAgNPs, and group D normal saline. Body weight was measured weekly and fasting blood glucose was measured fortnightly. At the end of the experiment, animals were euthanized and organs (livers and kidneys) were fixed in neutral buffered formalin and processed for light microscopy (H&E). Body weight differences were significantly higher (P < 0.05) in the low-dose Cc group and the kidney to body weight ratio was not significant. Renal function analysis of proteins and ketones showed a significant increase in CcAgNP-treated rats (P < 0.05). Kidney and liver histology showed distortions in hepatocytes and sinusoidal linings with infiltrations especially in the higher dose groups. Kidney histology mirrored degenerative changes in glomerular and Bowman's capsules with bfirillary mesangial interstitium. CcAgNPs impairs renal and hepatic morphology and function after a long period of administration.
This study investigated the toxic effects of silver on the kidneys and livers of Sprague-Dawley rats after administering multiple doses of silver nanoparticles synthesized using extracts of Cinnamomum cassia (CcAgNPs). Twenty-four Sprague-Dawley rats (250 ± 20 g) were randomly assigned to four groups (A-D) of six animals per group and treated for 8 weeks. Group A was administered 200 mg/kg of Cinnamon Cassia extract (Cc), group B 5 mg/kg of CcAgNPs, group C 10 mg/kg of CcAgNPs, and group D normal saline. Body weight was measured weekly and fasting blood glucose was measured fortnightly. At the end of the experiment, animals were euthanized and organs (livers and kidneys) were fixed in neutral buffered formalin and processed for light microscopy (H&E). Body weight differences were significantly higher (P < 0.05) in the low-dose Cc group and the kidney to body weight ratio was not significant. Renal function analysis of proteins and ketones showed a significant increase in CcAgNP-treated rats (P < 0.05). Kidney and liver histology showed distortions in hepatocytes and sinusoidal linings with infiltrations especially in the higher dose groups. Kidney histology mirrored degenerative changes in glomerular and Bowman's capsules with bfirillary mesangial interstitium. CcAgNPsimpairs renal and hepatic morphology and function after a long period of administration.
Silver nanoparticles (AgNPs) have gained unique attention
because of their attractive properties, including their
high surface to volume proportions, reactant properties,
and antimicrobial impact
(Okafor et al., 2013)
. This is
particularly relevant in the health sciences as it opens new
frontiers in drug synthesis and delivery needed to target
some of the sanctuary sites difficult for normal therapeutic
doses of drugs to penetrate
(Peter et al., 2018)
. However,most techniques used for the synthesis of nanoparticles
(NPs) are costly and may negatively influence biological
systems. Therefore, green synthesis using plant
materials offers a relatively more secure and ecofriendly
methodology for NP synthesis and has been readily
adopted for silver nanomaterials. Plants offer an attractive
system for NP synthesis because of their capacity to deliver
an extensive variety of optional metabolites with weak
potential for toxicity. Plant extracts offer less biohazard,
are environmentally friendly, and are less delicate to
handle compared to microscopic organisms and therefore
offer a green option for biosynthesis, such as AgNPs
(Pandey et al., 2013)
. It is pertinent to mention that some
plants are already being exploited in this technique for
green nanoparticle synthesis, including the leaves of Olea
europaea and the bark of the Cinnamomum zeylanicum
tree, used as a part of conventional prescriptions in Turkey
and in other nations
(Kumar et al., 2013)
.Cinnamomum cassia, also known as Chinese cassia
or Chinese cinnamon, is an evergreen tree originating
from southern China and widely cultivated there and
elsewhere in southern and eastern Asia (India, Indonesia,
Laos, Malaysia, Taiwan, Thailand, and Vietnam). In South
Africa, mostly in the KwaZulu-Natal region, it is used as a
spice and for medicinal remedy in various illnesses, such
as diabetes.
Lee (2002)
earlier reported its antidiabetic
property in vitro. Cinnamomum cassia extracts offer
additional qualities for use in NP synthesis due to their
phytoconstituents (phenolics and flavonoids), which act
as capping agents providing stability to Ag nanoparticles
with the ability to control the size and shape of NPs by
giving extra layers to them
(Ahmed et al., 2016)
.Plant-based AgNP utilization in medicine and
pharmaceutical interventions may become the way to
go owing to the availability, nontoxicity, multitargeting
mechanism of action, and variety of metabolites that
facilitate reduction of Ag ions in biological systems
(Webster et al., 1992)
. Cinnamon cassia AgNPs have
been reported to be less toxic and also enhanced antiviral
activity against the H7N3influenza A virus
(Fatima et al.,
2016)
. However,
Yun et al. (2018)
in a recent study revealed
that high-dose intake of cinnamon extract (2000 mg/kg)
showed potential nephrotoxicity and hepatotoxicity to
both males and females as evidenced by obvious increases
of kidney/liver weight along with a small but statistically
significant elevation of total cholesterol level.The study by
Shakeel et al. (2018)
, however, found that
cinnamon extracts showed a significant ameliorative role
in the antioxidant system in response to elevated levels
of titanium dioxide nanoparticles or titanium dioxide
bulk salt-induced oxidative stress with recovery of the
antioxidant system as well as histological damages and
some hematological parameters in rat livers treated with
titanium dioxide nanoparticles or titanium dioxide bulk
salt. There is therefore no consensus with respect to the
safety of AgNPs or their conjugates
(Connor et al., 2005;
Khlebtsov and Dykman, 2011)
, warranting further
investigations.Our laboratory has utilized various animal models to
demonstrate potential interactions of plant-based adjuvants
in many therapeutic conditions for diabetes
(Ismail et al.,
2017)
, hypertension
(Azu, 2015)
, and alcohol-induced
antiretroviral toxicity
(Ogedengbe et al., 2018)
, exploring
various markers for biochemical, immunological, and
histomorphometric studies. The aim of this study was to
evaluate and report the histopathological and biochemical
effects of CcAgNPs in male Sprague-Dawley rats after
multiple oral administrations.
2. Materials and methods
2.1. Collection of plant material
Pure Cinnamomum cassia powder was purchased from
Warren Chemistry Specialties (Pty.) Ltd., Cape Town,
South Africa (reference 492733), during winter break,
and silver nitrate (AgNO ) was obtained from Capital
3
Laboratory (Pty.), KwaZulu-Natal.
2.2. Preparation of Cinnamomum cassia (Cc) aqueous plant extracts
For the preparation of C. cassia aqueous extracts,
approximately 10 g of the powdered plant material (bark)
was added to 300 mL of double-distilled water and allowed
to boil for 10 min at 45 °C according to the method of
Shankar et al. (2017)
. The resulting mixture was filtered
and stored in a refrigerator at 4 °C until analyzed.
2.3. Synthesis of Cinnamomum cassia silver nanoparticles (CcAgNPs)
AgNO3 was added to C. cassia extract (100 mL) to form
the AgNPs
(Ali et al., 2016; Elobeid, 2016)
. The formation
of AgNPs was observed by a change of color
(Shankar et
al., 2015)
.
2.4. Structural analysis of CcAgNPs
Figure 1a shows the ultraviolet-visible (UV-Vis) spectra
of CcAgNPs, which are in line with previous results that
reported that the UV-Vis absorption spectrum with a
distinct peak at 445 nm indicated a surface plasmon
resonance for AgNPs, ranging from 2 to 100 nm in size
(Shahverdi et al., 2007)
.
Figure 1
a) UV-Vis absorption spectra for Cinnamomum cassia silver nanoparticles (CcAgNPs), b) FTIR spectra of aqueous
Cinnamomum cassia silver nanoparticles (CcAgNPs), c) TEM images of Cinnamomum cassia silver nanoparticles (CcAgNPs), d) XRD
patterns of Cinnamomum cassia silver nanoparticles (CcAgNPs).
Fourier transform infrared spectroscopy (FTIR)
showed an absorbance peak at 3270 cm–1 (OH stretch),
2921 cm–1 (C-H stretch), and 1604 cm–1 (C = C stretch),
indicating the presence of polyphenols and conjugation
in the extracts (Figure 1b). Our results displayed a peak
at about 500 nm, which is supported by transmission
electron microscopy (TEM) analysis revealing that the
NPs are of smaller size (Figure 1c). The absorbance peak
confirmed the formation of AgNPs.Additionally, TEM (Figure 1c) images confirmed that
the morphology of the CcAgNPs was highly variable
with a variety of shapes (spherical, longitudinal, and
irregular). Their size variations were from 12 to 42 nm.
Nanoparticle behavior appears to be a function of size
and shape. Moreover, X-ray difraction (XRD) (Figure 1d)
analysis showed six distinct difraction peaks. The strong
peak of silver (1646.63 and 44.693 nm) followed by two
medium peaks at 468.56 and 310.62 nm indicated that the
biosynthesized NPs were indeed made up of only silver.a) UV-Vis absorption spectra for Cinnamomum cassiasilver nanoparticles (CcAgNPs), b) FTIR spectra of aqueous
Cinnamomum cassiasilver nanoparticles (CcAgNPs), c) TEM images of Cinnamomum cassiasilver nanoparticles (CcAgNPs), d) XRD
patterns of Cinnamomum cassiasilver nanoparticles (CcAgNPs).
2.5. Experimental animals
Twenty-four pathogen-free male Sprague-Dawley rats
weighing 250 ± 20 g were selected for the experimental
study. They were kept and maintained under laboratory
conditions of temperature of 21.5–22 °C, humidity of 60
± 1%, and a 12-h light/dark cycle. They were allowed free
access to food (standard pellets) and water. Animals were
allowed to acclimatize for 7 days in order to avoid causing
stress during the experimental period. Experimental
protocols and procedures used in this study were approved
by the institutional ethics committee of the University of
KwaZulu-Natal, ethics reference number AREC/074/016D.
2.6. Measurement of blood glucose
Thereafter, animals were kept under observation. Fasting
blood glucose was measured on days 0, 14, 28, 42, and 56.
Animals were tested using Roche Accu Chek Active 50
blood glucose strips (Dischem, South Africa), with blood
collected from the tail vein of the rats at 1000 hours daily.
2.7. Experimental design
In this experiment, Sprague-Dawley rats were randomly
assigned to different groups. The following groups of six
animals each were treated. Group A comprised rats that
received Cc (200 mg/kg), orally, once per day. Group B
comprised rats administered a low dosage of CcAgNPs
(5 mg/kg), orally, once per day. Group C comprised rats
administered a higher dosage of CcAgNPs (10 mg/kg),
orally, once per day
(Sulaiman et al., 2015)
. CcAgNPs were
dissolved in normal saline and administered orally, once
daily, and group D comprised rats (the control) that also
received normal saline (1 mL). All administrations were
done at 1000 hours daily for 56 consecutive days, through a
rat gavage needle (Daisy and Saipriya, 2012). Body weight
was recorded every week in the morning between 0800 and
1000 hours using an electronic balance (Zeiss, Germany;
0.000 g). After 56 days of administration, all animals were
sacrificed using excess halothane anesthetic. Blood was
then collected via transcardial puncture for biochemistry.
Liver and kidney tissues were harvested after a laparotomy
and processed for light microscopic studies. In addition,
the weights of each kidney and liver were recorded.
2.8. Histopathological examination of kidney and liver tissues
Organs were washed in saline and fixed in 10% neutral
buffered formalin for 24 h. Samples were transferred to
70% ethanol
(Latendresse et al., 2002)
. They were then
processed using ascending grades of ethyl alcohol to
dehydrate the samples, and xylene was used as the clearing
agent. Samples were then mounted in molten Paraplast at
58–62 °C; slices of 4–5 μm were cut using a microtome
(HM 315 microtome, Walldorf, Germany) from the
prepared blocks and stained with hematoxylin and eosin
(H&E). Sections were viewed and photographed using
an Olympus light microscope (Olympus BX51, Olympus
Optical Co. Ltd., Tokyo, Japan) with an attached camera
(Olympus E-330).
2.9. Statistical analysis
All results are presented as the mean ± standard deviation
of the mean. Statistical investigations were done utilizing
one-way analysis of difference (ANOVA) followed by
Tukey’s post hoc tests utilizing Graph Pad Prism Version
5. This allowed statistical comparison between the
control and treated groups and statistical significance was
acknowledged at P < 0.05.
3. Results
3.1. Effect of CcAgNPs on weight of body and vital organs
The oral treatment of rats with low and high doses of
CcAgNPs (5 mg/kg and 10 mg/kg) impacted the body
weight of experimental animals compared to the control as
well as those treated with Cc. Body weight of experimental
rats treated with CcAgNPs at low doses increased
significantly compared to those treated with high doses
and the control (P < 0.05) (Table). In addition, weights of
kidneys and livers of rats were not different between those
treated at low doses of CcAgNPs and the control as well
as the group treated with Cc and this was not statistically
significant at P < 0.05.
Table
Effect of Cinnamomum cassia silver nanoparticles (CcAgNPs) on weight of body and vital organs (mean ± SD, in mg).
Group
BWi
BWf
BWd
KW
BWKR
BWKRI
LW
BWLR
BWLRI
A
220± 6.6
220 ± 10
0
1.9 ± 0.14
0.89 ± 0.029
8.9
8.4 ± 0.70
0.0038 ± 0.002
0.38
B
310 ± 13
380 ± 17*
70. ±00
2.2 ± 0.67
0.005 ± 0.0003
0.5
12 ± 0.49
0.032 ± 0.003
3.2
C
310 ± 15
350 ± 23
40±.00
2.1 ± 0.08
0.006 ± 0.0006
0.6
12 ± 0.36
0.034 ± 0.002
3.4
D
320 8
360 ± 17*
40 ±00
2.4 ± 0.11
0.0067 ± 0.0003
0.67
13 ± 0.43
0.036 ± 0.021
3.6
*: Statistically significant (P < 0.05). Group A – rats treated with Cc, Group B – rats treated with low doses (5 mg/kg) of CcAgNPs,
Group C – rats treated with high doses (10 mg/kg) of CcAgNPs, and Group D – control.
BWi = Initial body weight, BWf = final body weight, BWd = body weight, KW = kidney weight, BWKR = body weight/kidney
ratio, BWKRI = body weight/kidney ratio index, LW = liver weight, BWLR = body weight/liver ratio AND BWLRI = body weight
liver ratio index.
Effect of Cinnamomum cassiasilver nanoparticles (CcAgNPs) on weight of body and vital organs (mean ± SD, in mg).*: Statistically significant (P < 0.05). Group A – rats treated with Cc, Group B – rats treated with low doses (5 mg/kg) of CcAgNPs,
Group C – rats treated with high doses (10 mg/kg) of CcAgNPs, and Group D – control.
BWi = Initial body weight, BWf = final body weight, BWd = body weight, KW = kidney weight, BWKR = body weight/kidney
ratio, BWKRI = body weight/kidney ratio index, LW = liver weight, BWLR = body weight/liver ratio AND BWLRI = body weight
liver ratio index.
3.2. Effect of CcAgNPs on blood glucose
It was observed that fasting blood glucose levels of control
animals were essentially similar to those of treated animals.
Animals in groups B and C treated with CcAgNPs (5 mg/
kg and 10 mg/kg, respectively) showed the same levels of
fasting blood glucose (Figure 2).
Figure 2
Effect of Cinnamomum cassia silver nanoparticles
(CcAgNPs) on blood glucose of Sprague-Dawley rats. Group
A – rats treated with Cc, Group B – rats treated with low
doses (5 mg/kg) of CcAgNPs, Group C – rats treated with
high doses (10 mg/kg) of CcAgNPs, and Group D – control.
Not statistically significant at P < 0.05.
Effect of Cinnamomum cassiasilver nanoparticles
(CcAgNPs) on blood glucose of Sprague-Dawley rats. Group
A – rats treated with Cc, Group B – rats treated with low
doses (5 mg/kg) of CcAgNPs, Group C – rats treated with
high doses (10 mg/kg) of CcAgNPs, and Group D – control.
Not statistically significant at P < 0.05.
3.3. Effect of CcAgNPs on renal function parameters
It was observed that protein, ketone, and hemoglobin
levels in the urine of control animals were lower than those
of treated animals. Animals in group B, treated with low
doses of CcAgNPs (5 mg/kg), showed a moderate presence
of protein, ketone, and hemoglobin in the urine, while
those in group C, treated with high doses of CcAgNPs (10
mg/kg), displayed considerable presence of urine markers
(Figure 3).
Figure 3
Effect of Cinnamomum cassia silver nanoparticles
(CcAgNPs) on renal function parameters of urine proteins,
ketones, and hemoglobin markers in Sprague-Dawley rats.
*: Statistically significant (P < 0.05). Group A – rats treated
with Cc, Group B – rats treated with low doses (5 mg/kg) of
CcAgNPs, Group C – rats treated with high doses (10 mg/kg)
of CcAgNPs, and Group D – control.
Effect of Cinnamomum cassiasilver nanoparticles
(CcAgNPs) on renal function parameters of urine proteins,
ketones, and hemoglobin markers in Sprague-Dawley rats.
*: Statistically significant (P < 0.05). Group A – rats treated
with Cc, Group B – rats treated with low doses (5 mg/kg) of
CcAgNPs, Group C – rats treated with high doses (10 mg/kg)
of CcAgNPs, and Group D – control.
3.4. Effect of CcAgNPs on the morphology of livers in
Histological sections of liver tissues of rats were prepared
and stained with the standard H&E technique and are
presented in Figures 4A-4D. Figure 4A shows a liver
section with outlines of hepatocytes showing nuclei that are
clearly visible while the central vein appears distorted with
loss of sinusoidal lining. Histologic sections of rats treated
with 5 mg/kg of CcAgNPs (Figure 4B) show a distorted
cytoarchitecture of hepatocytes, widened sinusoidal
spaces, and focal congestion in the central veins. There
are also infiltrations in the sinusoidal spaces. Rats treated
with 10 mg/kg of CcAgNPs (Figure 4C) showed severe and
generalized distortions in hepatocellular arrangement with
nuclear condensation and pyknosis and areas of vacuolar
changes suggestive of loss of liver architectural support/or
bifrosis. Sections of the control rats (Figure 4D) essentially
show normal hepatocytes lining sinusoidal spaces with arrays of radiation towards the central vein. Hepatocyte
nuclei are clearly visible and well stained.
Figure 4
Effect of Cinnamomum cassia silver nanoparticles
(CcAgNPs) on histological profile of liver in Sprague-Dawley
rats. Group A – rats treated with Cc, Group B – rats treated with
low doses (5 mg/kg) of CcAgNPs, Group C – rats treated with
high doses (10 mg/kg) of CcAgNPs, and Group D – control.
Blue arrow: central vein; green Arrow: hepatocytes.
Effect of Cinnamomum cassiasilver nanoparticles
(CcAgNPs) on histological profile of liver in Sprague-Dawley
rats. Group A – rats treated with Cc, Group B – rats treated with
low doses (5 mg/kg) of CcAgNPs, Group C – rats treated with
high doses (10 mg/kg) of CcAgNPs, and Group D – control.
Blue arrow: central vein; green Arrow: hepatocytes.
3.5. Effect of CcAgNPs on the morphology of kidneys of
Histological sections of kidney tissues of rats in the
group treated with Cc (Figure 5A) showed the outline of
renal corpuscles with glomeruli and Bowman’s capsular
space distinctly showing mild atrophy of glomeruli. The
nuclei of collecting tubules are identifiable and mesangial
materials are delineated, showing areas of vacuolar
changes. Sections from the kidney of rats treated with 5
mg/kg of CcAgNPs (Figure 5B) exhibited Bowman’s space
and glomerular tissue congestion suggestive of necrotic
changes. The mesangial tissues also showed nuclei of
tubules that appeared deeply stained and interspersed.
There was generalized atrophy of glomeruli with bfirillary
meshwork in kidney tissues of rats treated with 10 mg/kg
of CcAgNPs (Figure 5C) compared to the control (Figure
5D). In the control group (Figure 5D), histological sections
appear essentially normal with glomeruli and Bowman’s
capsular spaces depicting clear outlines with no detectable
pathology. The mesangium is essentially preserved with
nuclei of tubules visible and normal.
Figure 5
Effect of Cinnamomum cassia silver nanoparticles
(CcAgNPs) on the histological profile of kidneys in Sprague-
Dawley rats. Group A – rats treated with Cc, Group B – rats
treated with low doses (5 mg/kg) of CcAgNPs, Group C – rats
treated with high doses (10 mg/kg) of CcAgNPs, and Group
D – control. G: Glomeruli; blue arrow: Bowman’s space; green
arrow: nuclei.
Effect of Cinnamomum cassiasilver nanoparticles
(CcAgNPs) on the histological profile of kidneys in Sprague-
Dawley rats. Group A – rats treated with Cc, Group B – rats
treated with low doses (5 mg/kg) of CcAgNPs, Group C – rats
treated with high doses (10 mg/kg) of CcAgNPs, and Group
D – control. G: Glomeruli; blue arrow: Bowman’s space; green
arrow: nuclei.
4. Discussion
While the utilization of AgNPs for biomedical purposes
continues to grow, our insights and understanding of their
impacts on living cells and on biochemical structures
remains insufficient
(Adeyemi et al., 2015; Sulaiman et
al., 2015)
. In this study, we explored the effects of varied
doses of CcAgNPs on the livers and kidneys of
SpragueDawley rats following oral treatment. Although animals
treated with CcAgNPs showed no obvious signs of distress
during the experimental period, they appeared to be less
active and alert compared to the control group. There were
no clear differences between the skin colors of the groups.
Abdominal palpations did not reveal any abnormal mass,
which was confirmed at autopsy.Data from this study report changes in the body weight
and organ/body weight ratios. These changes in organ/
body weight ratios may be suggestive of toxicity subsequent
to the administration of CcAgNPs, as corroborated by
previous researchers who revealed that NPs altered body
and organ weights considerably
(Sulaiman et al., 2015)
.
Our results contrast with the reports of Song et al. (2017),
which showed that Cc extract administration significantly
decreased body weights, food intakes, and serum levels of
glucose in obesemice.While Cinnamomum cassia is commonly been used for
weight control in traditional medicines, this discordancy
may likely be attributed to the diverse experimental
design inherent in the two studies as well as other possible mechanistic pathways not clearly understood. Similarly,
aqueous extracts from cinnamon have been shown to
increase in vitro glucose uptake and glycogen synthesis
alongside increased phosphorylation of the insulin
receptor. These overall effects are likely to aid in triggering
the insulin cascade system with potential hypoglycemic
effects
(Jarvill-Taylor et al., 2001)
. Our results did not show
any significant changes in blood glucose levels between
the control group and treated animals, and neither did
CcAgNPs.As far as the histopathological studies were concerned,
they showed degenerative changes and atrophy in renal
and hepatic tissues of the rats treated with CcAgNPs in
this study and this was exacerbated in the group receiving
higher dose of CcAgNPs. Recent studies point to the
potential of NPs aggregating in tissues such as the liver,
which may provoke such observed alterations
(Sulaiman
et al., 2015)
even in liver cells of rats
(Hussain et al., 2005)
.While some authors proposed that AgNPs decrease
the action of mitochondria, which causes the reduction
of accessible vitality for cells
(Hussain et al., 2005)
, it is
also possible that damage to the hepatocytes could be
attributed to absorption of silver after oral administration
(Furchner et al., 1968)
. More so, Cc is reported to be used
for the treatment of diabetes, attributable to the phenolics
contained therein, and it is possible that its beneficial role
in diabetic nephropathy treatment is plausible.For renal markers of injury (ketones, proteins, and
albumin) as well as qualitative histological evaluations,
these derangements were more prominent with the higher
dose of CcAgNPs. In agreement with our study, other
studies reported toxic side effects on the renal tissue,
which subsequently impacted renal function
(Vasanth
and Kurian, 2017)
, but this does not agree with studies by
Luo et al. (2013)
and Yan et al. (2015), possibly due to the
fact that refined active compounds were tested directly or
perhaps due to the differences in the experimental design
as some were tested on animals in diabetic states.Although our study did not report antioxidant markers,
Cc has been reported to be rich in type A polyphenols,
demonstrated to be responsible for improvements in
fasting glucose even in clinical trial subjects
(Anderson
et al., 2008)
. The extract has also shown a significant
ameliorative role in the antioxidant system in response
to elevated levels of titanium dioxide nanoparticles or
titanium dioxide bulk salt-induced oxidative stress with
restoration of the histological damages in rat livers treated
with titanium dioxide nanoparticles or titanium dioxide
bulk salt (Shakeel et al., 2017).In conclusion, our findings revealed that biosynthesized
silver nanoparticles using extracts from Cinnamomum
cassia (CcAgNPs) caused injury to vital organs such as
the liver and kidneys in normal healthy rats. The toxic
effects appear related to the internal deposition of AgNPs,
which in turn appeared dose-related. It is recommended
that detailed immunological and electron microscopic
evaluations of the tissues be carried out alongside other
markers of liver/kidney injuries (biochemical assays for
enzymes) in order to clearly establish specific alterations
according to the dosage of CcAgNPs used.
Acknowledgments
We acknowledge the College of Health Sciences, UKZN,
for financial support to doctoral student Kofi Kouame.
This work was supported in part by grants of the National
Research Foundation of South Africa to the senior author
(OOA; Grant U99053) and to Dr Roshila Moodley (Grant
94041). We also thank the School of Chemistry and Physics,
UKZN (Westville Campus), and especially the support of
Judie Magura and Bongisiwe Shelembe. The authors also
acknowledge the UKZN Nanotechnology Platform.
Authors: Asmaa M Shehata; Fatma M S Salem; Eiman M El-Saied; Sahar S Abd El-Rahman; Mohamed Y Mahmoud; Peter A Noshy Journal: Biol Trace Elem Res Date: 2021-04-14 Impact factor: 3.738